Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.10.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Effect of HLA Class II Gene Disparity on Clinical Outcome in Unrelated Donor Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia: The US National Marrow Donor Program Experience

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Outcomes From Unrelated Donor Hematopoietic Stem Cell Transplantation

Cancer Control
MedicineOncologyHematology
2011English

Alternative Donor Sources for Hematopoietic Stem Cell Transplantation

2013English

Unrelated Donor Marrow Transplantation for Myelodysplastic Syndromes: Outcome Analysis in 510 Transplants Facilitated by the National Marrow Donor Program

Blood
BiochemistryImmunologyCell BiologyHematology
2002English

Qualifications and Training of Adult Stem Cell Donor Recruiters: Recommendations by the World Marrow Donor Association

Bone Marrow Transplantation
TransplantationHematology
2012English

Donor-Derived Myeloid Neoplasm Post Allogeneic Hematopoietic Cell Transplantation

Blood
BiochemistryImmunologyCell BiologyHematology
2017English

American Society of Blood and Marrow Transplantation Guidelines for Training in Hematopoietic Progenitor Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

National Marrow Donor Program

2011English

National Marrow Donor Program

2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy